Related Experiment Video

Updated: Jun 28, 2026

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
07:21

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice

Published on: September 28, 2015

Possible pathogenic link between migraine and urotensin-II

Ugur Bicak1, Hamza Karabiber, Halil I Ozerol

  • 1Department of Pediatrics, Inonu University Medical School, Malatya, Turkey.

Journal of Child Neurology
|November 6, 2008
PubMed

Insights

Migraine patients show significantly lower plasma levels of human urotensin-II (hU-II) compared to healthy controls. These findings suggest a potential role for hU-II in migraine pathogenesis.

Area of Science:

  • Neuroscience
  • Endocrinology

Background:

  • Human urotensin-II (hU-II) is a vasoactive peptide implicated in various physiological and pathological processes.
  • Understanding the role of neuropeptides in migraine pathogenesis is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate and compare plasma levels of human urotensin-II (hU-II) in individuals with migraine and healthy controls.
  • To explore the potential association between hU-II levels and migraine pathogenesis.

Main Methods:

  • A case-control study involving 27 migraine patients and 27 healthy controls.
  • Venous blood samples were collected from all participants twice to measure plasma hU-II levels.
  • Statistical analysis was performed to compare hU-II levels between groups and subgroups.

Main Results:

  • Plasma hU-II levels were significantly lower in migraine patients (0.483 pg/mL during episodes, 0.493 pg/mL between episodes) compared to controls (0.737 pg/mL).
  • No significant differences in hU-II levels were observed based on sex, age, migraine type, or duration within the patient group.
  • The observed lower hU-II levels in migraineurs suggest a potential pathophysiological link.

Conclusions:

  • Reduced plasma hU-II levels may be a contributing factor in the pathogenesis of migraine.
  • Further research is warranted to elucidate the specific mechanisms by which hU-II influences migraine development and progression.

More Related Videos

Investigating Migraine-Like Behavior Using Light Aversion in Mice05:23

Investigating Migraine-Like Behavior Using Light Aversion in Mice

Published on: August 11, 2021

Related Concept Videos

Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...